Hsbc Global Res Upgrades Coloplast A/S (OTCMKTS:CLPBY) to Hold

Hsbc Global Res upgraded shares of Coloplast A/S (OTCMKTS:CLPBY) from a moderate sell rating to a hold rating in a research note issued to investors on Monday morning,Zacks.com reports.

Coloplast A/S Trading Down 1.9 %

Shares of OTCMKTS:CLPBY opened at $12.36 on Monday. The company’s 50 day moving average price is $13.04 and its two-hundred day moving average price is $12.86. Coloplast A/S has a 12-month low of $10.69 and a 12-month high of $14.34. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.56 and a current ratio of 0.85.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.08 earnings per share (EPS) for the quarter. The business had revenue of $1.02 billion for the quarter. Coloplast A/S had a net margin of 18.69% and a return on equity of 31.17%. As a group, sell-side analysts predict that Coloplast A/S will post 0.38 earnings per share for the current year.

Coloplast A/S Increases Dividend

The business also recently disclosed a dividend, which will be paid on Friday, December 20th. Investors of record on Monday, December 9th will be paid a $0.2435 dividend. This is an increase from Coloplast A/S’s previous dividend of $0.05. The ex-dividend date of this dividend is Monday, December 9th. Coloplast A/S’s dividend payout ratio is presently 27.27%.

About Coloplast A/S

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.